Last reviewed · How we verify
Bacterial infection due to Klebsiella pneumoniae
Approved treatments
- MEZLOCILLIN
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Cefradex · Bristol-Myers Squibb
- Cefaprin · Bristol-Myers Squibb
- Tobi · Novartis
- Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug. - Claforan · Sterimax
- Avelox · Bayer AG
Fourth-generation fluoroquinolone with the broadest spectrum, covering gram-positive, gram-negative, anaerobic, and atypical organisms. - Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug that inhibits bacterial cell wall synthesis. - Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Cefepim · University Hospital Tuebingen
- Ciprofloxacine · Poitiers University Hospital
- Vantobra · Pfizer
- Gentamicin · Merck & Co.
- Cefadole
Cefadole works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - ALATROFLOXACIN · Pfizer
- Nebcin · University Hospital, Lille
- Avelox · Novartis Pharmaceuticals
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent. - Primaxin · Merck Sharp & Dohme B.V.
Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Arikayce Kit · Bristol-Myers Squibb
Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria. - Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Monocid
- Teflaro · AbbVie
Teflaro works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Cefotan
- Primaxin · Merck & Co.
Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body. - AZLOCILLIN · Bayer Pharmaceuticals Corp
- Cephalotin · Eli Lilly
- TICARCILLIN
- Ticarcillin
- Sparcin
- Zinacef · GSK
Zinacef works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Augmentin 250 · Dr Reddys Labs Inc
- Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Noroxin
- Floxin
- Epocelin
- Cipro · Bayer AG
- Rocephin · Generic (originally Roche)
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Cephradin · Sohag University
- Ceftazidim · Tel-Aviv Sourasky Medical Center
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Clinical guidelines
- FDA label — 1L
Ceftazidime is indicated for the treatment of infections caused by susceptible strains of Klebsiella spp. - FDA label — 1L
Gentamicin Injection, USP is indicated in the treatment of serious infections of burn wounds caused by susceptible bacteria. - FDA label — 1L
Gentamicin Injection, USP is indicated in the treatment of serious infections caused by susceptible strains of Klebsiella-Enterobacter-Serratia species. - FDA label — 1L
Gentamicin Injection, USP is indicated in the treatment of serious infections caused by susceptible strains of Klebsiella-Enterobacter-Serratia species. - FDA label — 1L
Gentamicin Injection, USP is indicated in the treatment of serious infections of the skin caused by susceptible bacteria. - FDA label — 1L
Gentamicin Injection, USP is indicated in the treatment of serious bacterial infections of the central nervous system (meningitis) caused by susceptible bacteria. - FDA label — 1L
Gentamicin Injection, USP is indicated in the treatment of serious infections of the respiratory tract caused by susceptible bacteria. - FDA label — 1L
Gentamicin Injection, USP is indicated in the treatment of bacterial septicemia caused by susceptible bacteria.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bacterial infection due to Klebsiella pneumoniae patent landscape — cliff calendar, originator estates, attackable patents
- Bacterial infection due to Klebsiella pneumoniae treatment landscape brief
- Bacterial infection due to Klebsiella pneumoniae treatment updates RSS
Frequently asked questions about Bacterial infection due to Klebsiella pneumoniae
What drugs treat Bacterial infection due to Klebsiella pneumoniae?
Tracked treatments include MEZLOCILLIN, Ramycin, Garamycin, Cefradex, Cefaprin, Tobi, Maxipime, Claforan.
What is the treatment for Bacterial infection due to Klebsiella pneumoniae?
Standard treatment for Bacterial infection due to Klebsiella pneumoniae includes MEZLOCILLIN, Ramycin, Garamycin, Cefradex, Cefaprin. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Bacterial infection due to Klebsiella pneumoniae?
FDA label publishes guidelines for Bacterial infection due to Klebsiella pneumoniae. 8 guideline references tracked.
Related
- Treatment landscape: Bacterial infection due to Klebsiella pneumoniae patent cliff · Bacterial infection due to Klebsiella pneumoniae CI report
- Treatment: MEZLOCILLIN
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Cefradex · Bristol-Myers Squibb
- Treatment: Cefaprin · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing